# Malaria: Developing Drugs for Treatment: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/malaria-developing-drugs-for-treatment-draft-guidance-for-industry/3edfcacf-7736-421e-9b04-b883ec5cc173

> FDA guidance document: Malaria: Developing Drugs for Treatment: Draft Guidance for Industry. Issue date: September 23, 2025. Get complete insights and analysis.

---

## Details

- Title: Malaria: Developing Drugs for Treatment: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-09-23
- Last Changed: 2025-09-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2025-D-0918">FDA-2025-D-0918</a>

## Related Documents

- [Disseminated Coccidioidomycosis: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/disseminated-coccidioidomycosis-developing-drugs-for-treatment-draft-guidance-for-industry/e0cec7f3-429f-41d0-8670-617e61df8616)
- [Erosive Esophagitis: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment-draft-guidance-for-industry/db47ebb5-eadc-4f7b-a236-ac6b016c3ec7)
- [Monoclonal Antibodies: Streamlined Nonclinical Safety Studies: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/monoclonal-antibodies-streamlined-nonclinical-safety-studies-draft-guidance-for-industry/439cec36-0e7d-4c02-88e4-7a0af7b47fa4)